Healthy People 2010 Final Review Webinar (Part 3 of 7)

Uploaded by ODPHP on 10.09.2012

DR. EDWARD SONDIK: This shows, and we’ve picked five areas here to take a quick look
at. These are examples of charts that you’re going to find throughout the entire report,
okay. So if we look at the very first one, it’s immunization. I hope you can read this
over the web. It’s immunization, and the measure is or the objective is fully immunized
young children 19 to 35 months.
The 71.4 percent says that 71.4 percent, okay, of the target that had been set, of the distance
between where we were in 2000 and the target, actually had been met. So we’re not there.
If we drop down, and then I’ll give you more on this in a second, but if we drop down
to the dark blue line, that’s access to health care, and it’s one aspect of it.
It’s the decrease in -- what we’re seeking here is a decrease in hospitalizations for
pediatric asthma, feeling that in fact those hospitalizations can be decreased if there’s
appropriate care ahead of time. Here, 142 percent of the difference between where we
are in 2000 and where we wound up in the Year 2010 had actually been achieved. So it’s
a tremendous difference.
If we can go to the next slide, this provides the detail, on the next slide, that you need
to really understand these figures. Well, we seem to have actually missed something
here, but I’ll go onto this one and I’ll show you here with physical activity, or actually
with overweight and obesity. The table part on the right, okay, gives the figures for
the target, okay, for the baseline of the measure, for where we wound up, okay, and
then questions of the difference, the percent change, and whether or not the differences
were statistically significant.
And so for obesity in adults, we see the arrow on the left going, if you will, in the wrong
direction, okay, and the target was to be 15 percent, and starting out in `88 to `94
here in the baseline. We were at 23 percent of adults were obese, okay, adults being people
20 years or more of age. We wound up here at the end of this period, the data coming
from the NHANES program, at 34 percent.
So instead of going down, we actually went up by about almost 50 percent actually. It
says in the far right on that slide 47.8 percent. So we have a chart like this for every one
of the 733 objectives in which that we could evaluate, which really summarizes where we
were, where we are, did we make progress, and in effect, I guess that’s the bottom
Now there’s other data as well in here. If we could go to the next slide. Let’s
turn to a couple of the reasons, I guess one could say, that the longevity has increased,
and that longevity has increased because the leading causes of death have actually decreased.
The first one we’re looking at is overall cancer mortality, which pardon me... [pause]…
Oh. I’m giving stage directions… But in any case, so what we’ve got here is a considerable
decrease in this, which I think is about 11 percent, if I recall correctly, in overall
cancer mortality. This is a decrease again that’s more than one percent per year, which
from a public health point of view, a statistical significance point of view, there’s no question
that it’s significant and extremely important.
At the same time, we didn’t meet the target. The dotted line is the target, and we lie
above that line. Going to the next slide, okay, we can see that in fact the rates by
race are quite different, okay. The overall rate, because of the prominence of the numbers
of the White population, is very similar to the overall total rate. Other rates for other
races are below, are below this and in effect are doing better than the target, and started
out doing better than the target.
The thing I want to draw your attention to, though, is the difference between the White
and the Black rate. The difference that was in 1999 in effect has persisted over the decade,
okay. Although there’s been some, the decrease among the Black population has actually been
greater and faster than the decrease among the White population.
So what we see here is progress, but we see persistent disparities, okay. If we look at
the next slide, this is an example of charts that we have throughout the report, showing
the geographic difference. Going to the next slide, many of the objectives have to do with
interventions, okay. This shows interventions related to colorectal, for colorectal cancer
screening, and so it’s a screening.
Here we see considerable progress, in fact more, doing better than the target in terms
of the rate of screening, and in fecal occult blood tests heading down, which in fact was
the recommendation. So we actually have done well in terms of that.
Going to the next slide, we turn to coronary heart disease, okay. If we look and we can
see the parallel lines here, the persistence of the differences by race, and if we look
at the end point on the next slide, which I thought would circle the end point, but
you can look just as well. At 2007, we can see that the Black rate persists as considerably
higher than the White rate, okay, with the Asian rate much, much lower. In effect, that’s
the best rate.